Stay updated on Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new build of the platform. There is no visible change to the study details or other content presented to users.
    Difference
    0.0%
    Check dated 2026-07-21T13:53:27.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous v3.6.0 tag. This signals an update to the page's template or content without changing the trial information.
    Difference
    0.0%
    Check dated 2026-06-30T02:40:37.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Enrollment status updated to 'No longer looking for participants', and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention / Treatment heading was reformatted to 'Intervention/Treatment', and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T22:11:38.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating an administrative update to the study record rather than a substantive change to study details.
    Difference
    0.0%
    Check dated 2026-06-08T18:06:45.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.3 to v3.5.4, indicating a small update to the study record metadata on ClinicalTrials.gov.
    Difference
    0.0%
    Check dated 2026-05-18T03:59:15.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was replaced with Taoyuan, Taiwan, 333 in the Locations section to standardize the city designation for the study site.
    Difference
    0.0%
    Check dated 2026-05-03T17:41:50.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk HCC Post-Hepatic Tx Clinical Trial page.